GeneDx Holdings Corp. (WGS) insider trading.
In Q3 2026, insiders at GeneDx Holdings Corp. reported 19 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 13 sales worth $1.8M.
- Transactions
- 19
- Purchases (P)
- 0
- Sales (S)
- 13
- Net shares, P minus S
- -19,578
- Insiders
- 3
- Last filed
- 2026-09-18
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Feeley Kevin | Officer · CHIEF FINANCIAL OFFICER | 10 | 0 | 7 |
| Stueland Katherine | Director, Officer · CHIEF EXECUTIVE OFFICER | 8 | 0 | 6 |
| Fuchs Thomas | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-17 | Fuchs Thomas | M (A) | 1,146 | $0 | 1,146 | Form 4 |
| 2026-09-16 | Stueland Katherine | S (D) | 4,141 | $98.27 | 118,515 | Form 4 |
| 2026-09-16 | Stueland Katherine | S (D) | 1,525 | $96.9 | 122,656 | Form 4 |
| 2026-09-16 | Stueland Katherine | S (D) | 148 | $95.41 | 124,181 | Form 4 |
| 2026-09-16 | Stueland Katherine | S (D) | 1,648 | $94.26 | 124,329 | Form 4 |
| 2026-09-16 | Stueland Katherine | M (A) | 18,750 | $0 | 125,977 | Form 4 |
| 2026-09-16 | Stueland Katherine | S (D) | 3,039 | $99 | 115,476 | Form 4 |
| 2026-09-16 | Feeley Kevin | M (A) | 7,197 | $0 | 48,673 | Form 4 |
| 2026-09-16 | Feeley Kevin | S (D) | 586 | $94.26 | 48,087 | Form 4 |
| 2026-09-16 | Feeley Kevin | S (D) | 1,079 | $99 | 44,945 | Form 4 |
| 2026-09-16 | Feeley Kevin | S (D) | 541 | $96.9 | 47,494 | Form 4 |
| 2026-09-16 | Feeley Kevin | S (D) | 1,470 | $98.27 | 46,024 | Form 4 |
| 2026-09-16 | Feeley Kevin | S (D) | 52 | $95.41 | 48,035 | Form 4 |
| 2026-09-09 | Stueland Katherine | M (A) | 6,547 | $0 | 110,919 | Form 4 |
| 2026-09-09 | Stueland Katherine | S (D) | 3,692 | $84.22 | 107,227 | Form 4 |
| 2026-09-09 | Feeley Kevin | M (A) | 2,462 | $0 | 42,761 | Form 4 |
| 2026-09-09 | Feeley Kevin | S (D) | 1,285 | $84.22 | 41,476 | Form 4 |
| 2026-09-01 | Feeley Kevin | S (D) | 372 | $83.84 | 40,299 | Form 4 |
| 2026-09-01 | Feeley Kevin | M (A) | 717 | $0 | 40,671 | Form 4 |
Transaction codes in this quarter
Get WGS insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1818331&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · WGS company page · GeneDx Holdings Corp. on SEC.gov
Questions
Are insiders buying or selling GeneDx Holdings Corp. (WGS)?
In Q3 2026, insiders at GeneDx Holdings Corp. reported 19 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 13 sales worth $1.8M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these GeneDx Holdings Corp. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/wgs.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.